ClinicalTrials.gg
Active, not recruitingNCT07716514Updated Jul 21, 2026

Interoceptive Awareness and Dream Themes

An observational study in Adult Women, sponsored by Recep Tayyip Erdogan University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by Recep Tayyip Erdogan University · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
307
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

Individual differences in reported dream themes may reflect not only waking emotional and cognitive experiences but also characteristic ways of attending to, interpreting, and regulating bodily signals. Associations between interoceptive awareness and dream themes may reflect variance shared with alexithymia, psychological distress, sleep disturbance, and somatic symptoms. This study examined whether six dimensions of subjective interoceptive awareness accounted for incremental variance in dream themes beyond established emotional, sleep-related, and somatic correlates in adult women.

Read the detailed description

Existing studies have primarily examined nightmares, nightmare distress, dream frequency, subjective sleepiness, or general sleep quality. They have not established whether multidimensional self-reported interoceptive awareness accounts for incremental variance in overall reported dream themes after emotional, sleep-related, somatic, and dream recall-related correlates are considered simultaneously. The present study therefore examined whether six dimensions of subjective interoceptive awareness jointly accounted for incremental variance in overall Dream Themes Scale scores among adult women beyond age, dream recall frequency, chronic disease, menopausal status, anxiety, depressive symptoms, alexithymia, subjective sleep quality, and somatic symptom burden. The primary hypothesis was that the six interoceptive-awareness dimensions would jointly account for a small but detectable increment in explained variance after the covariates had been entered.

02

Conditions studied

  • Adult Women

Keywords

  • Interoceptive awareness
  • Dream themes
  • Alexithymia
  • Psychological distress
  • Somatic symptoms
  • Sleep quality
03

In context

Affective Symptoms

85 studies on the registry are indexed under Affective Symptoms; 20 are open to participants now.

This study's planned enrollment of 307 is above the median of 70 across 21 observational studies indexed under Affective Symptoms.

Browse Affective Symptoms studies →

Lead sponsor

Recep Tayyip Erdogan University is the lead sponsor of 69 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

This cross-sectional observational study examines conditional associations between multidimensional subjective interoceptive awareness and self-reported dream themes in community-dwelling women aged 18-65 years.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • being 18-65 years old
  • being able to understand written Turkish
  • having sufficient cognitive capacity to complete the questionnaires
  • providing written .

Exclusion criteria

Exclusion Criteria:

  • were an active psychotic disorder
  • a severe neurological condition, or cognitive impairment that substantially interfered with questionnaire comprehension.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
307 participants (estimated)
Patient registry
No

Groups and cohorts

  • Community-dwelling women

    This cross-sectional observational study examined conditional associations between multidimensional subjective interoceptive awareness and self-reported dream themes in community-dwelling women aged 18-65 years.

06

What researchers measure

Primary outcomes

  1. Interoceptive Awareness

    Interoceptive awareness was assessed using the Turkish adaptation of the Multidimensional Assessment of Interoceptive Awareness, Version 2. The original MAIA-2 contains 37 items and eight dimensions. In the Turkish validation study, five original items were removed, producing a 32-item, six-factor solution comprising Emotional Awareness, Attention Regulation, Body Listening, Not-Distracting, Trusting, and Not-Worrying. Items are rated from 0 ("never") to 5 ("always"). Each dimension score was calculated as the mean of its constituent items after applying the direction of scoring specified for the administered form. Higher scores indicate a greater level of the tendency represented by the corresponding dimension.

    Time frame: At baseline

  2. Dream Themes

    The Dream Themes Scale (DTS) is a 29-item Turkish self-report measure assessing the frequency of themes in recalled dreams. Items are rated from 0 ("never") to 4 ("always"). The total score ranges from 0 to 116, with higher scores indicating more frequent endorsement of the assessed dream themes. The original development study identified five correlated dimensions: Negative Themes, Anxiety Themes, Fear Themes, Effects of Waking-Life Experiences, and Frustration Themes. The DTS total score was prespecified as the primary outcome and was used as a descriptive composite reflecting the overall frequency of endorsed dream themes across five related domains. The five DTS subscales were additionally examined as secondary outcomes to evaluate whether the observed associations were domain-specific.

    Time frame: At baseline

Other outcomes

  1. Emotional, sleep-related, and somatic covariates

    Alexithymic characteristics were assessed with the 20-item Toronto Alexithymia Scale and its Turkish adaptation. Total scores range from 20 to 100, with higher values indicating greater alexithymic characteristics. Somatic symptom burden during the preceding four weeks was assessed using the 15-item Patient Health Questionnaire and the Turkish PHQ-SADS validation. Items are rated from 0 to 2 and summed to produce a total score ranging from 0 to 30. Higher scores indicate greater somatic symptom burden. Subjective sleep quality during the preceding month was measured using the Pittsburgh Sleep Quality Index and its Turkish adaptation. Seven component scores are summed to produce a global score ranging from 0 to 21, with higher scores indicating poorer subjective sleep quality.

    Time frame: At baseline

07

Study locations

1 site
  • RTEU Guneysu FTRYO
    Rize, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — I do not prefer

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07716514
Lead sponsor
Recep Tayyip Erdogan University
Responsible party
Seda Karaca (Research Assistant Dr., Recep Tayyip Erdogan University) — Principal investigator
First posted
Jul 21, 2026
Start date
Jul 1, 2026
Primary completion
Aug 1, 2026 (estimated)
Completion
Aug 10, 2026 (estimated)
Last update
Jul 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion